CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Clinical trial NCT05187182 · RECRUITING
Trial details
- NCT number
- NCT05187182
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-02
- Primary completion
- 2028-07-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.